CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

The Life Sciences Industry Outlook

Life Sciences Review | Monday, July 20, 2020
Tweet

Interoperability, patient experience, and inclusive clinical trials are trends expected to shape the future of life sciences companies in the coming years.


FREMONT, CA: The life sciences industry is at an inflection point. To prepare for the future and remain competitive in the ever-evolving business landscape, life sciences organizations are looking for new ways to create value and new metrics to make sense. Here is a look at the factors driving these changes and outlines suggestions on how life sciences organizations can aspire to find real value for themselves in the coming years. 


Based on the massive volume of available data and needs to be analyzed, radical interoperability is the ultimate vision of life sciences companies today. To achieve interoperability of massive quantities of data, created by regulators, customers, patients, doctors, and caregivers, and produced by wearable devices, sensors, life sciences companies this year will likely spend more time exploring cloud platforms. Health data, coupled with AI, could also lead to the development of personalized electronic health that can fundamentally change the patient experience and the human experience.


 


Technology companies are likely to enter the life sciences sector in 2020, possibly even faster than in previous years. They might create new internet-connected devices. Some healthcare companies are already functioning using AI and interoperable data, building architectures, and platforms where future data will reside. Many large health systems have announced plans to migrate their clinical data to cloud platforms run by large technology companies. Cloud storage combined with AI will likely accelerate the pace of medical research, which could lead to more precise treatments and cures.


Clinical trials are essential to medical research, but they must represent the patients who will use the drug or therapy to have statistical value. As such, today's life sciences companies are looking to change the way they think about the clinical-trial model. It appears that more companies will experiment with mobile-driven clinical trial models to reach larger, diverse populations if companies reimagine the way these trials are run. The life sciences industry moves closer to the promise of true precision medicine and a future of health. 2020 is likely to be seen as the year life sciences companies finally move past their 20th-century models and step into a new era.


See also: Top Cloud Based Planning Companies


 


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-life-sciences-industry-outlook--nwid-83.html